Literature DB >> 16157269

Cracking addiction the second time around: reconsolidation of drug-related memories.

Pepe J Hernandez1, Ann E Kelley.   

Abstract

One of the greatest challenges in the understanding and treatment of addiction is cue-elicited relapse to drug use. The present findings of Miller and Marshall and Lee et al. reported in this issue of Neuron demonstrate that retrieved drug-related memories undergo reconsolidation and thus suggest that these maladaptive associations may be more labile than previously thought.

Mesh:

Substances:

Year:  2005        PMID: 16157269     DOI: 10.1016/j.neuron.2005.09.001

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  5 in total

1.  Garcinol: A Magic Bullet of Amnesia for Maladaptive Memories?

Authors:  Rita A Fuchs; Ryan J McLaughlin
Journal:  Neuropsychopharmacology       Date:  2016-08-23       Impact factor: 7.853

Review 2.  Advancing addiction treatment: what can we learn from animal studies?

Authors:  Peter H Wu; Kalynn M Schulz
Journal:  ILAR J       Date:  2012

3.  A double blind, placebo-controlled study of the effects of post-retrieval propranolol on reconsolidation of memory for craving and cue reactivity in cocaine dependent humans.

Authors:  Michael E Saladin; Kevin M Gray; Aimee L McRae-Clark; Steven D Larowe; Sharon D Yeatts; Nathaniel L Baker; Karen J Hartwell; Kathleen T Brady
Journal:  Psychopharmacology (Berl)       Date:  2013-03-05       Impact factor: 4.530

Review 4.  Drug-induced alterations in the extracellular signal-regulated kinase (ERK) signalling pathway: implications for reinforcement and reinstatement.

Authors:  Haifeng Zhai; Yanqin Li; Xi Wang; Lin Lu
Journal:  Cell Mol Neurobiol       Date:  2007-11-28       Impact factor: 5.046

5.  Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling.

Authors:  Deborah C Mash; Jarlath ffrench-Mullen; Nikhil Adi; Yujing Qin; Andrew Buck; John Pablo
Journal:  PLoS One       Date:  2007-11-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.